Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First-In-Human Study to Demonstrate the Preliminary Safety and Efficacy of the Angioshield System to Provide Mechanical Support for Vein Grafts Used in CABG Surgery

NCT02072239 is registered in ClinicalTrials.gov with Neograft Technologies, Incorporated as lead sponsor.

NCT NCT02072239
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02072239 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First-In-Human Study to Demonstrate the Preliminary Safety and Efficacy of the Angioshield System to Provide Mechanical Support for Vein Grafts Used in CABG Surgery
Lead sponsor
Neograft Technologies, Incorporated
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2014
Completion date
July 31, 2015
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease